Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurie Galvan

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Frontiers in Synaptic Neuroscience|May 30, 2019
Major Contribution of Somatostatin-Expressing Interneurons and Cannabinoid Receptors to Increased GABA Synaptic Activity in the Striatum of Huntington's Disease MiceSandra M Holley, Laurie Galvan, Talia Kamdjou, et al.
Plos Currents|February 26, 2013
Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington's DiseaseJane Y Chen, Elizabeth Wang, Laurie Galvan, et al.
Molecular Autism|January 20, 2021
Major motor and gait deficits with sexual dimorphism in a Shank3 mutant mouse modelEmmanuel Matas, Alexandre Maisterrena, Mathieu Thabault, et al.
PNAS Nexus|April 15, 2024
Dysfunction of striatal parvalbumin interneurons drives motor stereotypies in Cntnap2-/- mouse model of autism spectrum disordersMathieu Thabault, Cloé Fernandes-Gomes, Anne-Lise Huot, et al.
The European Journal of Neuroscience|January 19, 2023
Age-related behavioural and striatal dysfunctions in Shank3<sup>ΔC/ΔC</sup> mouse model of autism spectrum disorderMathieu Thabault, Valentine Turpin, Éric Balado, et al.
Eneuro|July 24, 2015
Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington's DiseaseSandra M Holley, Prasad R Joshi, Anna Parievsky, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 26, 2013
Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse modelsCarlos Cepeda, Laurie Galvan, Sandra M Holley, et al.
Neurobiology of Aging|January 27, 2015
Striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivoLaetitia Francelle, Laurie Galvan, Marie-Claude Gaillard, et al.
Human Molecular Genetics|November 16, 2014
Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's diseaseLaetitia Francelle, Laurie Galvan, Marie-Claude Gaillard, et al.
Brain : a Journal of Neurology|February 26, 2016
CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's diseaseLydie Boussicault, Sandro Alves, Antonin Lamazière, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Frontiers in Synaptic Neuroscience|May 30, 2019
Major Contribution of Somatostatin-Expressing Interneurons and Cannabinoid Receptors to Increased GABA Synaptic Activity in the Striatum of Huntington's Disease MiceSandra M Holley, Laurie Galvan, Talia Kamdjou, et al.
Plos Currents|February 26, 2013
Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington's DiseaseJane Y Chen, Elizabeth Wang, Laurie Galvan, et al.
Molecular Autism|January 20, 2021
Major motor and gait deficits with sexual dimorphism in a Shank3 mutant mouse modelEmmanuel Matas, Alexandre Maisterrena, Mathieu Thabault, et al.
PNAS Nexus|April 15, 2024
Dysfunction of striatal parvalbumin interneurons drives motor stereotypies in Cntnap2-/- mouse model of autism spectrum disordersMathieu Thabault, Cloé Fernandes-Gomes, Anne-Lise Huot, et al.
The European Journal of Neuroscience|January 19, 2023
Age-related behavioural and striatal dysfunctions in Shank3<sup>ΔC/ΔC</sup> mouse model of autism spectrum disorderMathieu Thabault, Valentine Turpin, Éric Balado, et al.
Eneuro|July 24, 2015
Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington's DiseaseSandra M Holley, Prasad R Joshi, Anna Parievsky, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 26, 2013
Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse modelsCarlos Cepeda, Laurie Galvan, Sandra M Holley, et al.
Neurobiology of Aging|January 27, 2015
Striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivoLaetitia Francelle, Laurie Galvan, Marie-Claude Gaillard, et al.
Human Molecular Genetics|November 16, 2014
Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's diseaseLaetitia Francelle, Laurie Galvan, Marie-Claude Gaillard, et al.
Brain : a Journal of Neurology|February 26, 2016
CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's diseaseLydie Boussicault, Sandro Alves, Antonin Lamazière, et al.
Pageof 3